197 related articles for article (PubMed ID: 25327666)
1. Development and validation of a prediction model for diagnosing blood stream infections in febrile, non-neutropenic children with cancer.
Esbenshade AJ; Pentima MC; Zhao Z; Shintani A; Esbenshade JC; Simpson ME; Montgomery KC; Lindell RB; Lee H; Wallace A; Garcia KL; Moons KG; Friedman DL
Pediatr Blood Cancer; 2015 Feb; 62(2):262-268. PubMed ID: 25327666
[TBL] [Abstract][Full Text] [Related]
2. Multisite external validation of a risk prediction model for the diagnosis of blood stream infections in febrile pediatric oncology patients without severe neutropenia.
Esbenshade AJ; Zhao Z; Aftandilian C; Saab R; Wattier RL; Beauchemin M; Miller TP; Wilkes JJ; Kelly MJ; Fernbach A; Jeng M; Schwartz CL; Dvorak CC; Shyr Y; Moons KGM; Sulis ML; Friedman DL
Cancer; 2017 Oct; 123(19):3781-3790. PubMed ID: 28542918
[TBL] [Abstract][Full Text] [Related]
3. A prediction model for bacteremia and transfer to intensive care in pediatric and adolescent cancer patients with febrile neutropenia.
Alali M; Mayampurath A; Dai Y; Bartlett AH
Sci Rep; 2022 May; 12(1):7429. PubMed ID: 35523855
[TBL] [Abstract][Full Text] [Related]
4. Prospective Implementation of a Risk Prediction Model for Bloodstream Infection Safely Reduces Antibiotic Usage in Febrile Pediatric Cancer Patients Without Severe Neutropenia.
Esbenshade AJ; Zhao Z; Baird A; Holmes EA; Dulek DE; Banerjee R; Friedman DL
J Clin Oncol; 2020 Sep; 38(27):3150-3160. PubMed ID: 32762614
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of febrile, nonneutropenic pediatric oncology patients with central venous catheters who are not given empiric antibiotics.
Bartholomew F; Aftandilian C; Andrews J; Gutierrez K; Luna-Fineman S; Jeng M
J Pediatr; 2015 Jan; 166(1):157-62. PubMed ID: 25444524
[TBL] [Abstract][Full Text] [Related]
6. Prospective External Validation of the Esbenshade Vanderbilt Models Accurately Predicts Bloodstream Infection Risk in Febrile Non-Neutropenic Children With Cancer.
Zhao Z; Patel PA; Slatnick L; Sitthi-Amorn A; Bielamowicz KJ; Nunez FA; Walsh AM; Hess J; Rossoff J; Elgarten C; Myers R; Saab R; Basbous M; Mccormick M; Aftandilian C; Richards R; Nessle CN; Tribble AC; Sheth Bhutada JK; Coven SL; Runco D; Wilkes J; Gurunathan A; Guinipero T; Belsky JA; Lee K; Wong V; Malhotra M; Armstrong A; Jerkins LP; Cross SJ; Fisher L; Stein MT; Wu NL; Yi T; Orgel E; Haeusler GM; Wolf J; Demedis JM; Miller TP; Esbenshade AJ
J Clin Oncol; 2024 Mar; 42(7):832-841. PubMed ID: 38060973
[TBL] [Abstract][Full Text] [Related]
7. Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia.
Patel PA; DeGroote NP; Jackson K; Cash T; Castellino SM; Jaggi P; Esbenshade AJ; Miller TP
Cancer; 2022 Dec; 128(23):4129-4138. PubMed ID: 36238979
[TBL] [Abstract][Full Text] [Related]
8. The identification of febrile, neutropenic children with neoplastic disease at low risk for bacteremia and complications of sepsis.
Lucas KG; Brown AE; Armstrong D; Chapman D; Heller G
Cancer; 1996 Feb; 77(4):791-8. PubMed ID: 8616774
[TBL] [Abstract][Full Text] [Related]
9. Bacteremia in nonneutropenic pediatric oncology patients with central venous catheters in the ED.
Moskalewicz RL; Isenalumhe LL; Luu C; Wee CP; Nager AL
Am J Emerg Med; 2017 Jan; 35(1):20-24. PubMed ID: 27765482
[TBL] [Abstract][Full Text] [Related]
10. Applying a risk prediction model for bloodstream infection in a febrile, nonseverely neutropenic cohort of pediatric stem cell transplant patients.
Jackson K; Anderson V; Zhao Z; Kitko CL; Connelly JA; Ho RH; Banerjee R; Dulek DE; Friedman DL; Esbenshade AJ
Cancer; 2023 May; 129(10):1591-1601. PubMed ID: 36828805
[TBL] [Abstract][Full Text] [Related]
11. Association Between Depth of Neutropenia and Clinical Outcomes in Febrile Pediatric Cancer and/or Patients Undergoing Hematopoietic Stem-cell Transplantation.
Alali M; David MZ; Danziger-Isakov LA; Bartlett AH; Petty LA; Schwartz T; Pisano J
Pediatr Infect Dis J; 2020 Jul; 39(7):628-633. PubMed ID: 32176187
[TBL] [Abstract][Full Text] [Related]
12. Bacteremia in febrile nonneutropenic pediatric oncology patients.
Kelly MJ; Vivier PM; Panken TM; Schwartz CL
Pediatr Blood Cancer; 2010 Jan; 54(1):83-7. PubMed ID: 19774640
[TBL] [Abstract][Full Text] [Related]
13. Clinical parameters associated with low bacteremia risk in 1100 pediatric oncology patients with fever and neutropenia.
Baorto EP; Aquino VM; Mullen CA; Buchanan GR; DeBaun MR
Cancer; 2001 Aug; 92(4):909-13. PubMed ID: 11550165
[TBL] [Abstract][Full Text] [Related]
14. A clinical approach to non-neutropenic fever in children with cancer.
AlAzmi A; Jastaniah W; AlDabbagh M; Elimam N
J Oncol Pharm Pract; 2021 Apr; 27(3):560-569. PubMed ID: 32476589
[TBL] [Abstract][Full Text] [Related]
15. Bacteremia in Febrile, Non-neutropenic, and Well-appearing Children With Cancer.
Beauchemin M; Marshall AF; Ricci AM; Lopez ID; Yao Y; Lee A; Jin Z; Sulis ML
J Pediatr Hematol Oncol; 2022 Jan; 44(1):e194-e198. PubMed ID: 34001793
[TBL] [Abstract][Full Text] [Related]
16. Value of electronic data for model validation and refinement: bacteremia risk in children with fever and neutropenia.
Madsen K; Rosenman M; Hui S; Breitfeld PP
J Pediatr Hematol Oncol; 2002 May; 24(4):256-62. PubMed ID: 11972092
[TBL] [Abstract][Full Text] [Related]
17. Predictors of bacteremia in febrile children 3 to 36 months of age.
Isaacman DJ; Shults J; Gross TK; Davis PH; Harper M
Pediatrics; 2000 Nov; 106(5):977-82. PubMed ID: 11061763
[TBL] [Abstract][Full Text] [Related]
18. Clinical decision rule for obtaining peripheral blood cultures in febrile oncology patients.
Gorfinkel L; Hansen CE; Teng W; Shabanova V; Prozora S; Rodwin R; Qadri U; Manghi T; Emerson B; Riera A
Pediatr Blood Cancer; 2022 May; 69(5):e29519. PubMed ID: 34939321
[TBL] [Abstract][Full Text] [Related]
19. Predictors of occult pneumococcal bacteremia in young febrile children.
Kuppermann N; Fleisher GR; Jaffe DM
Ann Emerg Med; 1998 Jun; 31(6):679-87. PubMed ID: 9624306
[TBL] [Abstract][Full Text] [Related]
20. Is current initial empirical antibiotherapy appropriate to treat bloodstream infections in short-duration chemo-induced febrile neutropenia?
Joncour A; Puyade M; Michaud A; Tourani JM; Cazenave-Roblot F; Rammaert B
Support Care Cancer; 2020 Jul; 28(7):3103-3111. PubMed ID: 31667604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
